For instance, HACE1 deficiency increases the proliferative and metastatic capabilities of liver cancer cells and is associated with malignant pathological features and poor patient survival rates 9 Moreover, HACE1 exerts tumor-suppressive effects in digestive tract malignancies such as colorectal cancer 10 and gastric cancer 11. The gene discussed is HACE1; the disease is colorectal cancer.